IGF-1 might be the next big thing in autism treatment

Published July 12, 2016

This week’s podcast summarizes a new neural stem cell study and a recent review article on IGF-1 treatment in developmental disorders. IGF stands for Insulin Growth Factor and is essential for generation of new neurons, and shaping and health of existing neurons. Patients with autism spectrum disorder are already starting to be treated with IGF-1, and this week results from neural stem cells showed it is a valid biological target for autism treatment. If you are interested in participating in a research trial at Mt. Sinai School of Medicine using IGF-1, call the Seaver Center at 212-241-0961.

IGF-1 might be the next big thing in autism treatment

Filed under: